Menu UF Health Home Menu
 
Staud_2
Staud_2

UF researchers to study new fibromyalgia pain medications

Current treatments do little to relieve the constant, intense pain suffered by an estimated 6 to 12 million Americans with fibromyalgia. UF researchers hope to change that.

Prev Next

Welcome

This Division is responsible for the evaluation and management of patients with diseases of the musculoskeletal system at the University of Florida Shands Hospital and the Gainesville VAMC. There is an inpatient consultation service and active outpatient clinics, which serve as a regional and international referral center for the management of rheumatic diseases.

There is a strong research interest in the systemic autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, scleroderma, polymyositis and vasculitis. Faculty research activities are reflected in the Division’s clinical activities, which increasingly are orientated toward specialized outpatient units for managing complex disorders of the immune system. The centerpiece of these efforts is the newly established Autoimmune Disease Center, which is mandated to promote understanding of the causes of systemic autoimmunity and the identification of more effective approaches to the prevention, early diagnosis, and treatment of these diseases.

Our overall strategy includes:

  1. Developing disease-specific multidisciplinary clinical units to provide accurate diagnostic information and high quality, efficient patient care
  2. Promoting basic and translational clinical research aimed at defining the causes of systemic autoimmunity
  3. Using advanced diagnostic approaches and biological markers for monitoring disease and identifying complications
  4. Studying new approaches to the therapy of autoimmune diseases, and
  5. Providing educational programs for patients, residents, fellows, and attending physicians

This is an exciting time in clinical immunology and rheumatology. Recent major advances in basic immunology and immunogenetics are rapidly being translated into better therapies for immune diseases. The Division of Rheumatology and Clinical Immunology is committed to remaining at the cutting edge of these new technologies.

Westley H. Reeves, MD
Professor & Chair

Rheumatology Oxford JournalsSubscribe to this RSS Feed

Risk of work loss due to illness or disability in patients with osteoarthritis: a population-based cohort study

April 14, 2016

Objectives. To estimate the risk of work loss due to illness or disability in a cohort of employed persons with OA compared with matched non-OA individuals. ...

Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study

April 14, 2016

Objective. To investigate the association between the presence of aPL and/or LA and all-cause mortality among end-stage renal disease (ESRD) patients with and without SLE. ...

Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012

April 14, 2016

Objectives. To estimate the mortality associated with SLE during the period 1999–2012 by age, gender and region; and to ascertain the cause of death for people with SLE. ...

Use of biologics in SLE: a review of the evidence from a clinical perspective

April 14, 2016

With the explosion in biologics use in rheumatology, newer and smarter ways of using these drugs in different diseases have been advocated. SLE has to date been at the back of the biologics...